Compare TG Therapeutics Inc (TGTX) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Vistra Corp — how do they compare? TG Therapeutics Inc trades at $54.06 (market cap $8.26B), while Vistra Corp trades at $162.1 (market cap $53.27B). The key difference: Vistra Corp is far larger — about 6.4× TG Therapeutics Inc's market cap, and Vistra Corp pays a 0.58% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | VST | |
|---|---|---|
Market Cap | $8.26B | $53.27B |
Sector | Health | Technology |
52-Week High | $59.06 | $217.92 |
52-Week Low | $26.39 | $134.71 |
Enterprise Value | $8.50B | $75.03B |
Dividend Yield | — | 0.58% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
